<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/2065" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/2065/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/2065/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_2065"><akn:num>2065</akn:num><akn:heading>Improving the reliability of domestic medical isotope supply</akn:heading><akn:content><akn:p>§ 2065. Improving the reliability of domestic medical isotope supply(a) Medical isotope development projects(1) In generalThe Secretary shall carry out a technology-neutral program—(A) to evaluate and support projects for the production in the United States, without the use of highly enriched uranium, of significant quantities of molybdenum-99 for medical uses;

(B) to be carried out in cooperation with non-Federal entities; and

(C) the costs of which shall be shared in accordance with section 16352 of this title.


(2) CriteriaProjects shall be evaluated against the following primary criteria:(A) The length of time necessary for the proposed project to begin production of molybdenum-99 for medical uses within the United States.

(B) The capability of the proposed project to produce a significant percentage of United States demand for molybdenum-99 for medical uses.

(C) The capability of the proposed project to produce molybdenum-99 in a cost-effective manner.

(D) The cost of the proposed project.


(3) ExemptionAn existing reactor in the United States fueled with highly enriched uranium shall not be disqualified from the program if the Secretary determines that—(A) there is no alternative nuclear reactor fuel, enriched in the isotope U–235 to less than 20 percent, that can be used in that reactor;

(B) the reactor operator has provided assurances that, whenever an alternative nuclear reactor fuel, enriched in the isotope U–235 to less than 20 percent, can be used in that reactor, it will use that alternative in lieu of highly enriched uranium; and

(C) the reactor operator has provided a current report on the status of its efforts to convert the reactor to an alternative nuclear reactor fuel enriched in the isotope U–235 to less than 20 percent, and an anticipated schedule for completion of conversion.


(4) Public participation and reviewThe Secretary shall—(A) develop a program plan and annually update the program plan through public workshops; and

(B) use th</akn:p></akn:content><akn:subsection eId="subsec_2065_a"><akn:num>(a)</akn:num><akn:heading>Medical isotope development projects</akn:heading><akn:content><akn:p>(a) Medical isotope development projects</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2065_b"><akn:num>(b)</akn:num><akn:heading>Development assistance</akn:heading><akn:content><akn:p>(b) Development assistance The Secretary shall carry out a program to provide assistance for—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2065_c"><akn:num>(c)</akn:num><akn:heading>Uranium lease and take-back</akn:heading><akn:content><akn:p>(c) Uranium lease and take-back</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2065_d"><akn:num>(d)</akn:num><akn:heading>Coordination of environmental reviews</akn:heading><akn:content><akn:p>(d) Coordination of environmental reviews The Department and the Nuclear Regulatory Commission shall ensure to the maximum extent practicable that environmental reviews for the production of the medical isotopes shall complement and not duplicate each review.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2065_e"><akn:num>(e)</akn:num><akn:heading>Operational date</akn:heading><akn:content><akn:p>(e) Operational date The Secretary shall establish a program as described in subsection (c)(3) not later than 3 years after January 2, 2013.</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_2065_f"><akn:num>(f)</akn:num><akn:heading>Radioactive waste</akn:heading><akn:content><akn:p>(f) Radioactive waste Notwithstanding section 10101 of this title, radioactive material resulting from the production of medical isotopes that has been permanently removed from a reactor or subcritical assembly and for which there is no further use shall be considered low-level radioactive waste if the material is acceptable under Federal requirements for disposal as low-level radioactive waste.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>